These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 6958480

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.
    Johansson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P.
    Eur J Respir Dis Suppl; 1982; 122():74-82. PubMed ID: 6958496
    [Abstract] [Full Text] [Related]

  • 44. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.
    Ebden P, Jenkins A, Houston G, Davies BH.
    Thorax; 1986 Nov; 41(11):869-74. PubMed ID: 3547757
    [Abstract] [Full Text] [Related]

  • 45. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma.
    Boe J, Rosenhall L, Alton M, Carlsson LG, Carlsson U, Hermansson BA, Hetta L, Kiviloog J, Karlson BW, Lundbäck B.
    Allergy; 1989 Jul; 44(5):349-55. PubMed ID: 2669554
    [Abstract] [Full Text] [Related]

  • 46. The acute effects of corticosteroids in bronchial asthma.
    Ellul-Micallef R.
    Eur J Respir Dis Suppl; 1982 Jul; 122():118-25. PubMed ID: 6958475
    [Abstract] [Full Text] [Related]

  • 47. Beclomethasone dipropionate in asthma.
    Champion P, MacLean L, Chan-Yeung M.
    Can Med Assoc J; 1975 Aug 09; 113(3):213-8. PubMed ID: 1095170
    [Abstract] [Full Text] [Related]

  • 48. [Three month treatment with budesonide in patients with corticoid dependent bronchial asthma--personal experience].
    Frank-Piskorska A, Wasek Z, Jahnz-Rózyk K, Malinowski R, Lypka A, Jurkiewicz D, Witman D, Twarkowski P.
    Pol Tyg Lek; 1975 Aug 09; 45(29-31):620-4. PubMed ID: 2075133
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparison of budesonide and beclomethasone dipropionate for treatment of asthma.
    Springer C, Avital A, Maayan C, Rosler A, Godfrey S.
    Arch Dis Child; 1987 Aug 09; 62(8):815-9. PubMed ID: 3662586
    [Abstract] [Full Text] [Related]

  • 53. Comparison of inhaled budesonide with oral prednisolone at two dose-levels commonly used for the treatment of moderate asthma.
    Namsirikul P, Chaisupamongkollarp S, Chantadisai N, Bamberg P.
    Eur Respir J; 1989 Apr 09; 2(4):317-24. PubMed ID: 2737270
    [Abstract] [Full Text] [Related]

  • 54. High-dose beclomethasone inhaler in the treatment of asthma.
    Smith MJ, Hodson ME.
    Lancet; 1983 Feb 05; 1(8319):265-9. PubMed ID: 6130294
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Clinical pharmacology of corticosteroids in bronchial asthma.
    Lipworth BJ.
    Pharmacol Ther; 1993 Feb 05; 58(2):173-209. PubMed ID: 8415878
    [Abstract] [Full Text] [Related]

  • 57. Recovery of pituitary-adrenal axis after withdrawal or reduction of systemic corticosteroids in patients with bronchial asthma.
    Kunkel G, Meister J, Rudolph R, Staud RD, Baumgarten C, Kersten R.
    Allergol Immunopathol (Madr); 1979 Feb 05; 7(4):271-82. PubMed ID: 230736
    [Abstract] [Full Text] [Related]

  • 58. Personal observations on the use of inhaled corticosteroid drugs for chronic asthma.
    Toogood JH, Jennings B, Baskerville J, Lefcoe NM.
    Eur J Respir Dis; 1984 Jul 05; 65(5):321-38. PubMed ID: 6378649
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.